Tempus AI (TEM) is set to report Q3 earnings Monday, with analysts forecasting its first quarterly profit of $0.01/share since going public. This milestone comes as investors scrutinize the sustainability of its data business.
Key points to watch:
- Profitability Test: Expected $0.01 EPS marks a significant turnaround from a $0.04 loss in Q2 .
- Data Revenue Concerns: Top 5 customers account for 59% of revenue, with key contracts up for renewal. Competition from diagnostic peers and lack of exclusive EHR data rights pose potential risks .
- Pharma Partnerships: Recent expanded deals with Bristol Myers Squibb and Pathos AI could deliver up to $192.5M over five years, bolstering data value .
- Analyst Sentiment: Mean price target of $75.06 implies modest downside from current $77.84, with EPS estimates declining 5.21% over two months but ticking up recently .
Tempus AI faces profitability test as earnings loom Monday
INVESTING.COMNov 2, 9:52 AM UTC
0